Veterinary Medicines

CANIGEN 8 liofilizado y suspensión para suspensión inyectable para perros

Authorised
  • Canine distemper virus, strain Lederle VR128, Live
  • Canine adenovirus 2, strain Manhattan, Live
  • Canine parvovirus, strain Cornell 780916, Live
  • Canine parainfluenza virus, strain Manhattan, Live
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 601903, Inactivated
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 601895, Inactivated
  • Rabies virus, strain VP12, Inactivated
Download as PDF

Product identification

Medicine name:
CANIGEN 8 liofilizado y suspensión para suspensión inyectable para perros
Active substance:
  • Canine distemper virus, strain Lederle VR128, Live
  • Canine adenovirus 2, strain Manhattan, Live
  • Canine parvovirus, strain Cornell 780916, Live
  • Canine parainfluenza virus, strain Manhattan, Live
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 601903, Inactivated
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 601895, Inactivated
  • Rabies virus, strain VP12, Inactivated
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Canine distemper virus, strain Lederle VR128, Live
    5.00
    50% cell culture infectious dose
    /
    1.00
    Dose
  • Canine adenovirus 2, strain Manhattan, Live
    6.00
    50% cell culture infectious dose
    /
    1.00
    Dose
  • Canine parvovirus, strain Cornell 780916, Live
    7.00
    50% cell culture infectious dose
    /
    1.00
    Dose
  • Canine parainfluenza virus, strain Manhattan, Live
    7.00
    50% cell culture infectious dose
    /
    1.00
    Dose
  • Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 601903, Inactivated
    80.00
    percentage protection
    /
    1.00
    Dose
  • Leptospira interrogans, serovar Icterohaemorrhagiae, strain 601895, Inactivated
    80.00
    percentage protection
    /
    1.00
    Dose
  • Rabies virus, strain VP12, Inactivated
    1.00
    international unit(s)
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and suspension for suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AJ06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Virbac
Responsible authority:
  • Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 3125 ESP
Date of authorisation status change:

Documents

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 15/04/2025
Download

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 15/04/2025
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 15/04/2025
Download